Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.

Liu R, Yuan H, Yuan F, Yang SH.

Neurol Res. 2012 May;34(4):331-7. doi: 10.1179/1743132812Y.0000000020. Review.

PMID:
22643076
2.

The ischemic penumbra: identification, evolution and treatment concepts.

Fisher M.

Cerebrovasc Dis. 2004;17 Suppl 1:1-6. Review.

PMID:
14694275
3.

Evolving paradigms for neuroprotection: molecular identification of ischemic penumbra.

Castellanos M, Sobrino T, Castillo J.

Cerebrovasc Dis. 2006;21 Suppl 2:71-9. Epub 2006 May 2. Review.

PMID:
16651817
4.

Targeting the ischemic penumbra.

Ramos-Cabrer P, Campos F, Sobrino T, Castillo J.

Stroke. 2011 Jan;42(1 Suppl):S7-11. doi: 10.1161/STROKEAHA.110.596684. Epub 2010 Dec 16.

5.

SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.

PMID:
18462720
6.

Ischemic stroke intervention requires mixed cellular protection of the penumbra.

Barone FC.

Curr Opin Investig Drugs. 2009 Mar;10(3):220-3. Review.

PMID:
19333878
7.

Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.

Candelario-Jalil E.

Curr Opin Investig Drugs. 2009 Jul;10(7):644-54. Review.

PMID:
19579170
8.

The concept of ischemic penumbra in acute stroke and therapeutic opportunities.

Paciaroni M, Caso V, Agnelli G.

Eur Neurol. 2009;61(6):321-30. doi: 10.1159/000210544. Epub 2009 Apr 9. Review.

9.

The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011.

Heiss WD.

Cerebrovasc Dis. 2011;32(4):307-20. doi: 10.1159/000330462. Epub 2011 Sep 15. Review.

10.

The ischemic penumbra: a new opportunity for neuroprotection.

Fisher M.

Cerebrovasc Dis. 2006;21 Suppl 2:64-70. Epub 2006 May 2.

PMID:
16651816
11.

Treating acute ischemic stroke.

Fisher M, Bastan B.

Curr Opin Drug Discov Devel. 2008 Sep;11(5):626-32. Review.

PMID:
18729014
12.

Pathophysiology and therapy of experimental stroke.

Hossmann KA.

Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1057-83. Epub 2006 May 19. Review.

PMID:
16710759
14.

Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging.

Kidwell CS, Alger JR, Saver JL.

Stroke. 2003 Nov;34(11):2729-35. Epub 2003 Oct 23. Review.

15.
16.

New targets of neuroprotection in ischemic stroke.

Bacigaluppi M, Hermann DM.

ScientificWorldJournal. 2008 Jul 13;8:698-712. doi: 10.1100/tsw.2008.94. Review.

17.

Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?

Stankowski JN, Gupta R.

Antioxid Redox Signal. 2011 May 15;14(10):1841-51. doi: 10.1089/ars.2010.3292. Epub 2010 Oct 25. Review.

18.

Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.

Wahlgren NG, Ahmed N.

Cerebrovasc Dis. 2004;17 Suppl 1:153-66. Review.

PMID:
14694293
19.

Recommendations and treatment strategies for the management of acute ischemic stroke.

Segura T, Calleja S, Jordan J.

Expert Opin Pharmacother. 2008 May;9(7):1071-85. doi: 10.1517/14656566.9.7.1071. Review.

PMID:
18422467
20.

Neuroprotective agents in acute ischemic stroke.

Hock NH.

J Cardiovasc Nurs. 1998 Oct;13(1):17-25. Review.

PMID:
9785202
Items per page

Supplemental Content

Write to the Help Desk